ASCO 2024: Advances in lung cancer treatments and care

This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, studies presented at this year’s American Society of Clinical Oncology meeting highlight the ongoing advances in lung cancer treatments for earlier stages of the disease in specific populations. In addition, optimal timing of radiotherapy after radical prostatectomy points to salvage radiotherapy for prostate‐specific antigen failure, and the addition of apalutamide to androgen deprivation therapy after radical prostatectomy offers encouraging results.